// App-Quantinova.ai

SUN-053 : Hydrocortisone As an Intervention for Dexamethasone-Induced Side Effects in Pediatric Acute Lymphoblastic Leukemia Patients: Results of a Double-Blind Randomized Controlled Trial

Researchers

Presenter

  • Marry M van den Heuvel-Eibrink

Principal Investigators

  • Femke K Aarsen

  • Erica L.T. van den Akker

  • Saskia M.F. Pluijm

  • Marc B. Bierings

  • Cor van den Bos

  • Christian M. Zwaan

  • Helene H. Thygesen

  • Wim J.E. Tissing

  • Margreet A. Veening

  • Rob Pieters

Medical Centers

  • University Medical Center Utrecht, Utrecht, Netherlands

  • Universitair Medisch Centrum Groningen, Groningen, Netherlands

  • Erasmus MC, Rotterdam, Netherlands

  • Academic Medical Center, Amsterdam, Netherlands

  • Princess Maxima Center, Utrecht, Netherlands

  • Princess Maxima Center for Pediatric Oncology, Netherlands

  • Academic Medical Center, Amsterdam, Netherlands

  • Netherlands Cancer Institute (NKI), Amsterdam, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cortisol

Drug/Treatment

  • Hydrocortisone

  • Dexamethasone

  • Dekpak 13 Day Taperpak

Outcome

  • N/A

Study Design

  • randomized

  • cross over

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved